Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMU6TG7)

Drug Name
XMT-1592 Drug Info
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25.Y Phase 1/2 [1]
Ovarian cancer 2C73 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMU6TG7

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Sodium/phosphate cotransporter 2B (SLC34A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Upifitamab rilsodotin DMCWLHD Ovarian cancer 2C73 Phase 3 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sodium/phosphate cotransporter 2B (SLC34A2) TTQPZTM NPT2B_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT04396340) First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Mersana Therapeutics.
3 Clinical pipeline report, company report or official report of Mersana Therapeutics